{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib2mqaziviuh5uqb5p6qauxydmi5tgyyv2yrwtblqnzhyvdmw5spq",
    "uri": "at://did:plc:2b5g7cuquulsqdfp6uu33dxr/app.bsky.feed.post/3mf2fdsmbx572"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie667yymwk7slzeue2ev5atpoj4aihcg64n6yezsrrcu6genc6qlu"
    },
    "mimeType": "image/png",
    "size": 560450
  },
  "path": "/2026/02/17/deregulated-pricing-low-cost-chinese-apis-quadrupled-pakistans-pharma-profits-report/",
  "publishedAt": "2026-02-17T09:21:09.000Z",
  "site": "https://profit.pakistantoday.com.pk",
  "tags": [
    "Headlines",
    "Pharmaceuticals",
    "Deregulated pricing, low-cost Chinese APIs quadrupled Pakistan’s pharma profits: report",
    "Profit by Pakistan Today"
  ],
  "textContent": "Companies benefit from a stable exchange rate, a strong product pipeline, and a 35% drop in Chinese API costs; sector is projected to grow 35% YoY in 2026\n\nThe post Deregulated pricing, low-cost Chinese APIs quadrupled Pakistan’s pharma profits: report appeared first on Profit by Pakistan Today.",
  "title": "Deregulated pricing, low-cost Chinese APIs quadrupled Pakistan’s pharma profits: report"
}